• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

和 在透明细胞肾细胞癌中的作用。

The role of and expression in clear cell renal cell carcinoma.

机构信息

Department of Urology, Liaocheng People's Hospital, Liaocheng 252000, Shandong, China.

Department of Urology, Guanxian Center Hospital, Liaocheng 252500, Shandong, China.

出版信息

Biosci Rep. 2017 Nov 15;37(6). doi: 10.1042/BSR20171082. Print 2017 Dec 22.

DOI:10.1042/BSR20171082
PMID:28923830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5686392/
Abstract

The purpose of the study is to investigate the correlation between the expression of C-reactive protein () and autophagy-related 9B () and pathological features of clear cell renal cell carcinoma (CCRCC) patients. We also intended to explore the effects of manipulated expression of and on the apoptosis and cell cycle progression of CCRCC cell line. expression in CCRCC tissues and adjacent renal tissues was analyzed by immunohistochemistry (IHC). Gene expression was determined at transcription and translational levels using real-time quantitative PCR (RT-qPCR) and Western blot. The association between expression and clinical-pathological parameters including age, gender, pathological grades, TNM stage and distant metastasis of the patients was assessed by correlation analysis. siRNA and overexpression plasmids construction were used to manipulate the expression of in human CCRCC cell line 786-O. Cell apoptosis and cell cycle progression were determined using flow cytometry (FCM) and Hoechst 33258 staining. expression correlates with expression. The expression of and are significantly correlated with TNM staging, distant metastasis, and survival time of CCRCC patients. A high-level of indicates a poor overall survival (OS). In addition, expression influences cell cycle and apoptosis of CCRCC cells. The study reveals that might be a CCRCC development promoter. In addition, there is a close relationship between and in CCRCC carcinogenesis.

摘要

本研究旨在探讨 C 反应蛋白()与自噬相关蛋白 9B()的表达与透明细胞肾细胞癌(CCRCC)患者病理特征之间的相关性。我们还旨在探讨操纵和表达对 CCRCC 细胞系凋亡和细胞周期进程的影响。采用免疫组织化学(IHC)分析 CCRCC 组织和相邻肾组织中的表达。采用实时定量 PCR(RT-qPCR)和 Western blot 检测基因在转录和翻译水平上的表达。通过相关性分析评估表达与患者年龄、性别、病理分级、TNM 分期和远处转移等临床病理参数之间的关系。采用 siRNA 和过表达质粒构建来操纵人 CCRCC 细胞系 786-O 中的表达。采用流式细胞术(FCM)和 Hoechst 33258 染色测定细胞凋亡和细胞周期进程。表达与表达相关。和的表达与 TNM 分期、远处转移和 CCRCC 患者的生存时间显著相关。高水平的预示着总体生存率(OS)较差。此外,表达影响 CCRCC 细胞的细胞周期和凋亡。本研究表明可能是 CCRCC 发展的促进剂。此外,在 CCRCC 发生癌变过程中与之间存在密切关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/521ac91c5532/bsr-37-bsr20171082-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/af1d89802840/bsr-37-bsr20171082-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/afe8ff43370f/bsr-37-bsr20171082-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/7cea128a8d83/bsr-37-bsr20171082-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/37ffa0ae762c/bsr-37-bsr20171082-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/521ac91c5532/bsr-37-bsr20171082-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/af1d89802840/bsr-37-bsr20171082-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/afe8ff43370f/bsr-37-bsr20171082-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/7cea128a8d83/bsr-37-bsr20171082-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/37ffa0ae762c/bsr-37-bsr20171082-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b26/5686392/521ac91c5532/bsr-37-bsr20171082-g5.jpg

相似文献

1
The role of and expression in clear cell renal cell carcinoma.和 在透明细胞肾细胞癌中的作用。
Biosci Rep. 2017 Nov 15;37(6). doi: 10.1042/BSR20171082. Print 2017 Dec 22.
2
Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.Foxl1抑制肿瘤侵袭并可预测人类肾癌的预后。
Int J Clin Exp Pathol. 2013 Dec 15;7(1):110-22. eCollection 2014.
3
EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma.EZH2 通过增加透明细胞肾细胞癌中的 VEGF 表达促进肿瘤进展。
Clin Transl Oncol. 2015 Jan;17(1):41-9. doi: 10.1007/s12094-014-1195-5. Epub 2014 Jul 2.
4
YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.Yes相关蛋白(YAP)在肾透明细胞癌中过表达,敲低该蛋白可降低细胞增殖,并诱导细胞周期停滞和凋亡。
Oncol Rep. 2014 Oct;32(4):1594-600. doi: 10.3892/or.2014.3349. Epub 2014 Jul 22.
5
Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.在透明细胞肾细胞癌中,Dicer表达下调,并且在体外实验中,敲低Dicer可增强恶性表型转化。
Urol Oncol. 2014 Jan;32(1):46.e9-17. doi: 10.1016/j.urolonc.2013.06.011. Epub 2013 Oct 4.
6
High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.高水平的S100A6促进透明细胞肾细胞癌的转移并预测T1-T2期的预后。
Cell Biochem Biophys. 2015 Jan;71(1):279-90. doi: 10.1007/s12013-014-0196-x.
7
Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.FoxM1 的过表达与透明细胞肾细胞癌患者的肿瘤进展相关。
J Transl Med. 2012 Sep 24;10:200. doi: 10.1186/1479-5876-10-200.
8
Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.低水平的异柠檬酸脱氢酶 1 可预测透明细胞肾细胞癌患者术后的不良结局。
BMC Cancer. 2018 Aug 28;18(1):852. doi: 10.1186/s12885-018-4747-1.
9
Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.免疫组织化学染色法检测肌纤维连接蛋白在透明细胞肾细胞癌中的预后意义及其与表皮生长因子受体表达的关系。
Urol Oncol. 2019 Nov;37(11):812.e9-812.e16. doi: 10.1016/j.urolonc.2019.07.002. Epub 2019 Aug 14.
10
RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.RhoB作为一种肿瘤抑制因子,可抑制透明细胞肾细胞癌的恶性肿瘤特性。
PLoS One. 2016 Jul 6;11(7):e0157599. doi: 10.1371/journal.pone.0157599. eCollection 2016.

引用本文的文献

1
C-Reactive Protein Signaling Pathways in Tumor Progression.肿瘤进展中的C反应蛋白信号通路
Biomol Ther (Seoul). 2023 Sep 1;31(5):473-483. doi: 10.4062/biomolther.2023.132. Epub 2023 Aug 11.
2
ASCL2 Maintains Stemness Phenotype through ATG9B and Sensitizes Gliomas to Autophagy Inhibitor.ASCL2 通过 ATG9B 维持干细胞表型并使神经胶质瘤对自噬抑制剂敏感。
Adv Sci (Weinh). 2022 Sep;9(27):e2105938. doi: 10.1002/advs.202105938. Epub 2022 Jul 26.
3
Hydroxychloroquine Potentiates Apoptosis Induced by PPAR Antagonist in 786-O Clear Cell Renal Cell Carcinoma Cells Associated with Inhibiting Autophagy.

本文引用的文献

1
Therapeutic Effect of Sodium Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Renal Cell Carcinoma.钠-葡萄糖协同转运蛋白2抑制剂达格列净对肾细胞癌的治疗作用
Med Sci Monit. 2017 Aug 1;23:3737-3745. doi: 10.12659/msm.902530.
2
Relative Computed Tomography (CT) Enhancement Value for the Assessment of Microvascular Architecture in Renal Cell Carcinoma.相对计算机断层扫描(CT)增强值在评估肾细胞癌微血管结构中的应用。
Med Sci Monit. 2017 Jul 31;23:3706-3714. doi: 10.12659/msm.902957.
3
The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients.
羟氯喹啉增强PPAR拮抗剂诱导的786-O透明细胞肾癌细胞凋亡,这与抑制自噬有关。
PPAR Res. 2021 Apr 19;2021:6631605. doi: 10.1155/2021/6631605. eCollection 2021.
4
Relationship Between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma.血清炎症因子水平与分化型甲状腺癌的关系。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821990055. doi: 10.1177/1533033821990055.
5
Development of an Autophagy-Related Gene Prognostic Model and Nomogram for Estimating Renal Clear Cell Carcinoma Survival.用于评估肾透明细胞癌生存的自噬相关基因预后模型及列线图的开发
J Oncol. 2021 Feb 18;2021:8810849. doi: 10.1155/2021/8810849. eCollection 2021.
6
The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression.Pentraxin 家族的基本特征及其在肿瘤进展中的功能。
Front Immunol. 2020 Aug 18;11:1757. doi: 10.3389/fimmu.2020.01757. eCollection 2020.
7
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.差异表达的自噬相关基因是透明细胞肾细胞癌潜在的预后和诊断生物标志物。
Aging (Albany NY). 2019 Oct 17;11(20):9025-9042. doi: 10.18632/aging.102368.
8
Acute phase protein response to viral infection and vaccination.病毒感染和疫苗接种的急性期蛋白反应。
Arch Biochem Biophys. 2019 Aug 15;671:196-202. doi: 10.1016/j.abb.2019.07.013. Epub 2019 Jul 16.
C反应蛋白与白蛋白比值是一种经过验证的预后评分,可预测肾细胞癌手术患者的预后。
BMC Cancer. 2017 Mar 6;17(1):171. doi: 10.1186/s12885-017-3119-6.
4
Systemic Therapy for Metastatic Renal-Cell Carcinoma.转移性肾细胞癌的全身治疗
N Engl J Med. 2017 Jan 26;376(4):354-366. doi: 10.1056/NEJMra1601333.
5
Pituitary Metastasis from Renal Cell Carcinoma: Description of a Case Report.肾细胞癌垂体转移:一例病例报告描述
Am J Case Rep. 2017 Jan 3;18:7-11. doi: 10.12659/ajcr.901032.
6
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.在考虑C反应蛋白水平的情况下,对透明细胞肾细胞癌中预处理得出的中性粒细胞与淋巴细胞比值的潜在预后价值进行批判性评估。
Br J Cancer. 2017 Jan 3;116(1):85-90. doi: 10.1038/bjc.2016.393. Epub 2016 Dec 1.
7
Cytology diagnosis of metastatic clear cell renal cell carcinoma, synchronous to pancreas, and metachronous to thyroid and contralateral adrenal: Report of a case and literature review.胰腺同步、甲状腺及对侧肾上腺异时转移的透明细胞肾细胞癌的细胞学诊断:1例报告及文献复习
Diagn Cytopathol. 2017 Feb;45(2):161-167. doi: 10.1002/dc.23619. Epub 2016 Oct 22.
8
Overall prognostic impact of C-reactive protein level in patients with metastatic renal cell carcinoma treated with sorafenib.索拉非尼治疗转移性肾细胞癌患者中C反应蛋白水平的总体预后影响
Anticancer Drugs. 2016 Nov;27(10):1028-32. doi: 10.1097/CAD.0000000000000417.
9
Aberrant methylation of ATG2B, ATG4D, ATG9A and ATG9B CpG island promoter is associated with decreased mRNA expression in sporadic breast carcinoma.ATG2B、ATG4D、ATG9A和ATG9B基因启动子CpG岛的异常甲基化与散发性乳腺癌中mRNA表达降低有关。
Gene. 2016 Sep 30;590(2):285-92. doi: 10.1016/j.gene.2016.05.036. Epub 2016 Jun 3.
10
Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.术前中性粒细胞与淋巴细胞比值(NLR)、动态中性粒细胞与淋巴细胞比值(dNLR)、血小板与淋巴细胞比值(PLR)及C反应蛋白(CRP)在肾细胞癌手术患者中的预后价值
World J Urol. 2017 Feb;35(2):261-270. doi: 10.1007/s00345-016-1864-9. Epub 2016 Jun 2.